A randomized, part A partial blinded and part B double blinded, placebo-controlled 24-week clinical study to evaluate the efficacy and safety of nomacopan therapy in adult patients with bullous pemphigoid receiving adjunct oral corticosteroid therapy
Clinical Trial Grant
Administered By
Dermatology
Awarded By
Akari Therapeutics
Start Date
March 3, 2022
End Date
December 31, 2024
Administered By
Dermatology
Awarded By
Akari Therapeutics
Start Date
March 3, 2022
End Date
December 31, 2024